Skip to content

Clinical trials

Completed Phase 2 Hepatitis B trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Phase 2 Status: Completed Clear all

79 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20014
20021
20032
20046
20056
20064
20073
20082
20091
20108
20111
20122
20132
20141
20151
20161
20174
20184
20205
20216
20223
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed79

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline30
Gilead Sciences6
National Institute of Allergy and Infectious Diseases (NIAID)5
Sanofi Pasteur, a Sanofi Company3
Assembly Biosciences2
Brii Biosciences Limited2
Bristol-Myers Squibb2
Novartis2
Vir Biotechnology, Inc.2
Arbutus Biopharma Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B79
Hepatitis B, Chronic19
Tetanus18
Diphtheria17
Haemophilus Infections14
Poliomyelitis13
Hepatitis10
Whooping Cough8
HIV Infections6
Carcinoma, Hepatocellular3

Trials

Showing 1 to 25 of 79. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.